SCHEMBL4900337

SCHEMBL4900337

COc1ccc(F)c(CNc2c(Nc3ccc4[nH]cnc4c3)c(=O)c2=O)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3A P49840 4/20 0.48
ROCK1 Q13464 4/20 0.48
GSK3B P49841 3/20 0.48
PRKG1 Q13976 2/20 0.48
ROCK2 O75116 2/20 0.48
CLK4 Q9HAZ1 1/20 0.48
PRKACA P17612 3/20 0.47
RPS6KA3 P51812 3/20 0.47
CDC42BPA Q5VT25 3/20 0.47
AURKB Q96GD4 3/20 0.47
RPS6KB1 P23443 2/20 0.47
CSNK1G3 Q9Y6M4 2/20 0.47
ERBB2 P04626 1/20 0.47
IRAK1 P51617 1/20 0.47
QPCT Q16769 4/20 0.40
CHEK2 O96017 2/20 0.40
PRKCD Q05655 2/20 0.40
PRKAA1 Q13131 2/20 0.40
CDC7 O00311 1/20 0.40
PLK4 O00444 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4905527 0.86 ROCK1 (0.42) GSK3AROCK1GSK3BPRKG1ROCK2
SCHEMBL4596926 0.83 GSK3B (0.48) GSK3AROCK1GSK3BPRKG1ROCK2
SCHEMBL4598466 0.82 GSK3B (0.52) GSK3AROCK1GSK3BPRKG1ROCK2
SCHEMBL4598807 0.81 QPCT (0.50) GSK3AROCK1GSK3BPRKG1ROCK2
SCHEMBL4908200 0.80 QPCT (0.47) GSK3AROCK1GSK3BPRKG1ROCK2
SCHEMBL4907489 0.78 ROCK1 (0.39) GSK3AROCK1GSK3BPRKG1ROCK2
SCHEMBL4903241 0.77 ROCK1 (0.41) GSK3AROCK1GSK3BPRKG1ROCK2
SCHEMBL4910893 0.77 ROCK1 (0.47) GSK3AROCK1GSK3BPRKG1ROCK2
SCHEMBL4902107 0.77 ROCK1 (0.41) GSK3AROCK1GSK3BPRKG1ROCK2
SCHEMBL4898762 0.76 ROCK1 (0.41) GSK3AROCK1GSK3BPRKG1ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080234266-A1 Squaric Acid Derivatives II MERCK PATENT GESELLSCHAFT (DE) 2008-09-25 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080234266-A1 Squaric Acid Derivatives II CHEK2, CHEK1, SGK3 GSK3A 87/4885ROCK1 713/4885GSK3B 132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.